null The use of the CTIS system will be extended from 31.1.2023
The use of the CTIS system will be extended from 31.1.2023
11.1.2023 11:23 / News
The transition period according to the EU regulation on clinical drug trials (536/2014) ends for new research plans. From 31 January 2023 all new clinical drug trials must be submitted for evaluation by the authorities via the European Medicines Agency's CTIS system.